Inossia will be at NASS, October 12-15 in Chicago and Eurospine, October 19-21 in Milan.
May 04, 2022. We are happy to introduce our latest board member Mårten Winge. Mårten has an extensive executive management and advisory experience from life science startups and growth companies. Currently he is the CEO of Strike Pharma AB in Uppsala. Mårten has a broad international business network.Warm welcome Mårten as a valuable member of […]
March 17, 2022. We are happy to welcome a new center – Krankenhaus Mechernich – who has now joined our multicenter randomized clinical trial of soft cement V-Flex with the aim of including 150 patients in Europe. Dr. Robert Pflugmacher is joining Dr. David Eschman – UMM Universitätsmedizin Mannheim, Dr. Raquel Gutiérrez-González – Hospital Universitario […]
Our company is growing and we are happy to introduce our newest team member Christina Lidén as Inossia’s new Business Development Manager. Christina has extensive experience in customer relations, sales, marketing and project management, and has held leading positions in Sweden and international businesses, with a focus on the medical field. Warm welcome Christina!